Profound Medical (PROF) Competitors $6.74 +0.28 (+4.33%) Closing price 04:00 PM EasternExtended Trading$6.80 +0.05 (+0.82%) As of 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PROF vs. CLPT, SIBN, BVS, AVNS, ZIMV, BFLY, KIDS, TMCI, SMLR, and CBLLShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include ClearPoint Neuro (CLPT), SiBone (SIBN), Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), Butterfly Network (BFLY), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), and CeriBell (CBLL). These companies are all part of the "medical equipment" industry. Profound Medical vs. Its Competitors ClearPoint Neuro SiBone Bioventus AVANOS MEDICAL ZimVie Butterfly Network OrthoPediatrics Treace Medical Concepts Semler Scientific CeriBell Profound Medical (NASDAQ:PROF) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk. Which has more risk & volatility, PROF or CLPT? Profound Medical has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Comparatively, ClearPoint Neuro has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Which has preferable valuation and earnings, PROF or CLPT? ClearPoint Neuro has higher revenue and earnings than Profound Medical. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProfound Medical$10.68M19.01-$27.82M-$1.46-4.62ClearPoint Neuro$31.39M26.81-$18.91M-$0.81-36.54 Do analysts prefer PROF or CLPT? Profound Medical presently has a consensus price target of $11.00, indicating a potential upside of 63.20%. ClearPoint Neuro has a consensus price target of $19.67, indicating a potential downside of 33.56%. Given Profound Medical's higher probable upside, research analysts clearly believe Profound Medical is more favorable than ClearPoint Neuro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profound Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00ClearPoint Neuro 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is PROF or CLPT more profitable? ClearPoint Neuro has a net margin of -66.15% compared to Profound Medical's net margin of -343.97%. Profound Medical's return on equity of -89.74% beat ClearPoint Neuro's return on equity.Company Net Margins Return on Equity Return on Assets Profound Medical-343.97% -89.74% -73.06% ClearPoint Neuro -66.15%-94.44%-51.58% Does the media prefer PROF or CLPT? In the previous week, ClearPoint Neuro had 1 more articles in the media than Profound Medical. MarketBeat recorded 5 mentions for ClearPoint Neuro and 4 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.45 beat ClearPoint Neuro's score of 0.28 indicating that Profound Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ClearPoint Neuro 0 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders believe in PROF or CLPT? 47.9% of Profound Medical shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by insiders. Comparatively, 6.1% of ClearPoint Neuro shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryClearPoint Neuro beats Profound Medical on 11 of the 16 factors compared between the two stocks. Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$203.01M$2.64B$6.10B$10.65BDividend YieldN/A56.92%5.70%4.74%P/E Ratio-4.6223.6985.5527.59Price / Sales19.01785.33622.26138.47Price / CashN/A169.9037.7861.77Price / Book3.355.5313.136.76Net Income-$27.82M$32.78M$3.30B$275.88M7 Day Performance36.44%6.99%5.27%3.71%1 Month Performance63.99%14.04%9.93%10.21%1 Year Performance-12.47%0.79%87.76%35.85% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical1.3592 of 5 stars$6.74+4.3%$11.00+63.2%-14.8%$203.01M$10.68M-4.62150News CoverageAnalyst ForecastHigh Trading VolumeCLPTClearPoint Neuro0.6903 of 5 stars$21.57+0.1%$19.67-8.8%+144.4%$612.61M$31.39M-26.63110Analyst ForecastSIBNSiBone3.9824 of 5 stars$14.17+0.9%$23.67+67.0%+15.8%$606.13M$167.18M-25.30350Analyst ForecastBVSBioventusN/A$6.62-0.6%N/AN/A$550.64M$573.28M13.321,200Analyst ForecastAVNSAVANOS MEDICAL2.1228 of 5 stars$11.55-1.9%N/A-49.9%$546.16M$687.80M-1.152,227Positive NewsZIMVZimVie1.3999 of 5 stars$18.90-0.1%$17.75-6.1%+22.6%$533.47M$443.40M-27.001,770Analyst ForecastBFLYButterfly Network2.5164 of 5 stars$1.96-2.7%$3.00+53.5%+34.3%$506M$82.06M-6.98460News CoverageAnalyst ForecastOptions VolumeKIDSOrthoPediatrics4.6366 of 5 stars$18.31+0.2%$34.14+86.5%-26.8%$458.35M$204.73M-10.23200Positive NewsAnalyst ForecastTMCITreace Medical Concepts2.5785 of 5 stars$6.72+0.9%$9.83+46.3%+14.5%$420.73M$209.36M-8.51250News CoverageAnalyst ForecastSMLRSemler Scientific3.3124 of 5 stars$29.24+3.3%$74.25+153.9%+11.8%$419.12M$56.29M12.03120Analyst ForecastGap UpCBLLCeriBell2.637 of 5 stars$11.50+1.1%$32.14+179.5%N/A$416.87M$65.44M-3.85N/ANews CoverageAnalyst ForecastInsider Trade Related Companies and Tools Related Companies CLPT Competitors SIBN Competitors BVS Competitors AVNS Competitors ZIMV Competitors BFLY Competitors KIDS Competitors TMCI Competitors SMLR Competitors CBLL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PROF) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored"I'm risking my reputation on this"If I'm right about what's coming, this could be the most important book you'll read this yearCrypto 101 Media | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredGOLD ALERTGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
